{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:20:19Z","timestamp":1772835619368,"version":"3.50.1"},"reference-count":58,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.3201\/eid2502.180359","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T02:45:54Z","timestamp":1546742754000},"source":"Crossref","is-referenced-by-count":13,"title":["Public Health\u2013Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union"],"prefix":"10.3201","volume":"25","author":[{"given":"Adoraci\u00f3n","family":"Navarro-Torn\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finnian","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kersti\u00ebns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Aguar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Matthiessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2502.180359-201901052144-R1","unstructured":"European Centre for Disease Prevention and Control. Disease facts about seasonal influenza. 2018 [cited 2018 Jan 15]. https:\/\/ecdc.europa.eu\/en\/seasonal-influenza\/facts"},{"key":"key-10.3201\/eid2502.180359-201901052144-R2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"key-10.3201\/eid2502.180359-201901052144-R3","unstructured":"Jonung L, Roeger W. The macroeconomic effects of a pandemic in Europe. A model-based assessment. Vol. 44, Economic Papers. Brussels: European Commission Directorate-General for Economic and Financial Affairs; 2009."},{"key":"key-10.3201\/eid2502.180359-201901052144-R4","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States.","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"key-10.3201\/eid2502.180359-201901052144-R5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/risa.12625","article-title":"Total economic consequences of an influenza outbreak in the United States.","volume":"37","author":"Prager","year":"2017","journal-title":"Risk Anal"},{"key":"key-10.3201\/eid2502.180359-201901052144-R6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/irv.12570","article-title":"65\u00a0years of influenza surveillance by a World Health Organization-coordinated global network.","volume":"12","author":"Ziegler","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"key":"key-10.3201\/eid2502.180359-201901052144-R7","first-page":"E115","article-title":"History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.","volume":"57","author":"Barberis","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"key-10.3201\/eid2502.180359-201901052144-R8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/irv.12565","article-title":"The WHO global influenza surveillance and response system (GISRS)\u2014a future perspective.","volume":"12","author":"Hay","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"key":"key-10.3201\/eid2502.180359-201901052144-R9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions.","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"key-10.3201\/eid2502.180359-201901052144-R10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: Formulation and production strategies.","volume":"94","author":"Soema","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"key-10.3201\/eid2502.180359-201901052144-R11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing seasonal influenza\u2014the need for a universal influenza vaccine.","volume":"378","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2502.180359-201901052144-R13","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"US Flu VE Investigators. 2014\u20132015 influenza vaccine effectiveness in the United States by vaccine type.","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/cid\/cix608","article-title":"The household influenza vaccine effectiveness study: lack of antibody response and protection following receipt of 2014\u20132015 influenza vaccine.","volume":"65","author":"Petrie","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2014.03.008","article-title":"Immunosenescence: Influenza vaccination and the elderly.","volume":"29","author":"Haq","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"key-10.3201\/eid2502.180359-201901052144-R16","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza.","volume":"31","author":"Beyer","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.arr.2010.10.008","article-title":"Influenza vaccine responses in older adults.","volume":"10","author":"McElhaney","year":"2011","journal-title":"Ageing Res Rev"},{"key":"key-10.3201\/eid2502.180359-201901052144-R18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015.","volume":"36","author":"Jorgensen","year":"2018","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02091-17","article-title":"Pandemic paradox: early life H2N2 pandemic influenza infection enhanced susceptibility to death during the 2009 H1N1 pandemic.","volume":"9","author":"Gagnon","year":"2018","journal-title":"MBio"},{"key":"key-10.3201\/eid2502.180359-201901052144-R20","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.3390\/v6083159","article-title":"Options and obstacles for designing a universal influenza vaccine.","volume":"6","author":"Jang","year":"2014","journal-title":"Viruses"},{"key":"key-10.3201\/eid2502.180359-201901052144-R21","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","article-title":"Universal influenza vaccines: Shifting to better vaccines.","volume":"34","author":"Berlanda Scorza","year":"2016","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R22","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2502.180359-201901052144-R23","unstructured":"World Health Organization. SMTA2: Signed agreements and benefits. 2018 [cited 2018 Dec 17]. http:\/\/www.who.int\/influenza\/pip\/benefit_sharing\/smta2_signed\/en\/"},{"key":"key-10.3201\/eid2502.180359-201901052144-R24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines.","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"key-10.3201\/eid2502.180359-201901052144-R25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coviro.2016.02.002","article-title":"Novel universal influenza virus vaccine approaches.","volume":"17","author":"Krammer","year":"2016","journal-title":"Curr Opin Virol"},{"key":"key-10.3201\/eid2502.180359-201901052144-R26","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1073\/pnas.1519690113","article-title":"Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.","volume":"113","author":"Nakaya","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2502.180359-201901052144-R27","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S1473-3099(14)70963-6","article-title":"Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1\/2a clinical trial.","volume":"14","author":"Kreijtz","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R28","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3201\/eid2106.150021","article-title":"Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine.","volume":"21","author":"de Vries","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1517\/17425247.2012.697455","article-title":"Chitosan-based delivery systems for mucosal vaccines.","volume":"9","author":"Jabbal-Gill","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"key-10.3201\/eid2502.180359-201901052144-R30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The pathway to a universal influenza vaccine.","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"key":"key-10.3201\/eid2502.180359-201901052144-R31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza vaccination strategies: Comparing inactivated and live attenuated influenza vaccines.","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"key-10.3201\/eid2502.180359-201901052144-R32","doi-asserted-by":"publisher","first-page":"e0127969","DOI":"10.1371\/journal.pone.0127969","article-title":"Synthetic long peptide influenza vaccine containing conserved T and B cell epitopes reduces viral load in lungs of mice and ferrets.","volume":"10","author":"Rosendahl Huber","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2502.180359-201901052144-R33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/irv.12445","article-title":"Workshop report: Immunoassay standardisation for \u201cuniversal\u201d influenza vaccines.","volume":"11","author":"Pavlova","year":"2017","journal-title":"Influenza Other Respi Viruses"},{"key":"key-10.3201\/eid2502.180359-201901052144-R34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.tim.2013.04.003","article-title":"The prospects and challenges of universal vaccines for influenza.","volume":"21","author":"Subbarao","year":"2013","journal-title":"Trends Microbiol"},{"key":"key-10.3201\/eid2502.180359-201901052144-R35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/clpt.2011.321","article-title":"The innovative medicines initiative: a European response to the innovation challenge.","volume":"91","author":"Goldman","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.3201\/eid2502.180359-201901052144-R36","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/infdis\/jix165","article-title":"Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination.","volume":"215","author":"Mohn","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.180359-201901052144-R37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2016.04.014","article-title":"Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.","volume":"232","author":"Bernocchi","year":"2016","journal-title":"J Control Release"},{"key":"key-10.3201\/eid2502.180359-201901052144-R38","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1016\/j.vaccine.2016.10.040","article-title":"Influenza vaccine research funded by the European Commission FP7-Health-2013-Innovation-1 project.","volume":"34","author":"Liu","year":"2016","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R39","unstructured":"McCullough KC, Milona P, D\u00e9moulins T, Englezou P, Ruggli N. Dendritic cell targets for self-replicating RNA vaccines. J Blood Lymph. 2014;5:132."},{"key":"key-10.3201\/eid2502.180359-201901052144-R40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.vaccine.2016.10.024","article-title":"Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.","volume":"35","author":"Manenti","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12896-017-0396-8","article-title":"Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.","volume":"17","author":"Kazaks","year":"2017","journal-title":"BMC Biotechnol"},{"key":"key-10.3201\/eid2502.180359-201901052144-R42","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses"},{"key":"key-10.3201\/eid2502.180359-201901052144-R43","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2502.180359-201901052144-R44","unstructured":"European Investment Bank. InnovFin infectious diseases. 2018 [cited 2018 Dec 17]. http:\/\/www.eib.org\/products\/blending\/innovfin\/products\/infectious-diseases.htm"},{"key":"key-10.3201\/eid2502.180359-201901052144-R45","doi-asserted-by":"publisher","first-page":"e6339","DOI":"10.1097\/MD.0000000000006339","article-title":"Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.","volume":"96","author":"van Doorn","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid2502.180359-201901052144-R46","doi-asserted-by":"publisher","first-page":"e102505","DOI":"10.1371\/journal.pone.0102505","article-title":"Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment.","volume":"9","author":"Determann","year":"2014","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2502.180359-201901052144-R47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/13669877.2014.983947","article-title":"Why do parents who usually vaccinate their children hesitate or refuse? General good vs. individual risk.","volume":"19","author":"Gesser-Edelsburg","year":"2016","journal-title":"J Risk Res"},{"key":"key-10.3201\/eid2502.180359-201901052144-R48","first-page":"1","article-title":"I-MOVE+ hospital working group. Low 2016\u201317 season vaccine effectiveness against hospitalized influenza A(H3N2) among elderly: awareness warranted for 2017\u201318 season.","volume":"22","author":"Rondy","year":"2017","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2502.180359-201901052144-R49","first-page":"1","article-title":"I-MOVE\/I-MOVE + Study Team. Early 2016\u201317 vaccine effectiveness estimates against influenza A (H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.","volume":"22","author":"Kissling","year":"2017","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2502.180359-201901052144-R50","unstructured":"European Union. Council recommendation on seasonal influenza vaccination. Vol. L348. 2009 [cited 2017 Nov 16]. http:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32009H1019"},{"key":"key-10.3201\/eid2502.180359-201901052144-R51","unstructured":"European Union. Council conclusions on childhood immunization: successes and challenges of European childhood immunization and the way forward. 2011 [cited 2017 Nov 16]. http:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52011XG0708(02)&rid=2"},{"key":"key-10.3201\/eid2502.180359-201901052144-R52","unstructured":"European Union. Council conclusions on vaccinations as an effective tool in public health. 2014 [cited 2017 Nov 16]. http:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52014XG1206(01)&rid=8"},{"key":"key-10.3201\/eid2502.180359-201901052144-R53","unstructured":"European Commission. Vaccination. 2018 [cited 2018 Dec 17]. https:\/\/ec.europa.eu\/health\/vaccination\/overview_en"},{"key":"key-10.3201\/eid2502.180359-201901052144-R54","unstructured":"European Commission. Funding & tender opportunities. 2018 [cited 2018 Dec 17]. http:\/\/ec.europa.eu\/research\/participants\/portal\/desktop\/en\/opportunities\/h2020\/topics\/sc1- bhc-32-2019.html"},{"key":"key-10.3201\/eid2502.180359-201901052144-R55","unstructured":"United Nations. Sustainable development goals. 2018 [cited 2018 Dec 17]. https:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals"},{"key":"key-10.3201\/eid2502.180359-201901052144-R56","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/S0163-4453(17)30199-8","article-title":"Generalized herd effects and vaccine evaluation: impact of live influenza vaccine on off-target bacterial colonisation.","volume":"74","author":"Mina","year":"2017","journal-title":"J Infect"},{"key":"key-10.3201\/eid2502.180359-201901052144-R57","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.vaccine.2016.01.021","article-title":"Beyond efficacy: The full public health impact of vaccines.","volume":"34","author":"Saadatian-Elahi","year":"2016","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2502.180359-201901052144-R58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4065\/mcp.2009.0615","article-title":"Influenza vaccines: from surveillance through production to protection.","volume":"85","author":"Tosh","year":"2010","journal-title":"Mayo Clin Proc"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/2\/18-0359_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:27:13Z","timestamp":1732987633000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/2\/18-0359_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2502.180359","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}